Products for Topical Aesthetic and Post-Procedure Workflows
Medspas and aesthetic clinics need topical biologic supply, device compatibility, and documentation that medical directors can review. ExaVeyra supports NPI-verified medspa accounts with biomolecular signaling vesicles, post-procedure serums, microneedling devices and the CuraCator applicator.
Biomolecular signaling vesicles supplied in liquid format, cold-chain shipped, for topical aesthetic application by licensed practitioners.
Post-procedure serum procurement for medspas standardizing topical application workflows after microneedling protocols.
RF microneedling devices and standard microneedling pens commonly paired with topical biologic protocols.
Chemist-guided supplier documentation review covering particle size distribution, surface markers, sterility, and lot records.
All biomolecular signaling vesicles ship cold-chain in temperature-monitored packaging. Liquid format only.
COA per lot, NanoSight NTA characterization, and supporting supplier documentation available on request for approved accounts.
Regulatory notice
Exosome material. No exosome product is approved, cleared or licensed by the FDA for any use in humans, and statements on this site have not been evaluated by the FDA. Kimera exosome material is supplied to NPI-verified licensed practitioners for topical aesthetic use on the skin surface, including after procedures, as labeled by the manufacturer, and for laboratory research and clinical research conducted under an FDA investigational new drug application. It is not supplied for injection, infusion, inhalation, intranasal, ophthalmic or any other route into the body, and it is not intended to diagnose, treat, cure, mitigate or prevent any disease. Whether, how and in what setting it is used, and whether that use complies with scope of practice and state law, is the licensed practitioner’s responsibility. ExaVeyra Sciences is a supplier: it does not provide medical care, does not consult with patients and takes no part in clinical decisions. Research summaries describe published studies and are not claims about any product.
Compounded preparations. Compounded preparations are not FDA-approved, and the FDA does not verify their safety, effectiveness or quality before they are dispensed. Each preparation is compounded and dispensed by our 503A pharmacy partner, licensed by its state Board of Pharmacy, on a patient-specific prescription from a licensed prescriber; ExaVeyra Sciences does not compound, dispense or prescribe. ExaVeyra makes no claim that any preparation is safe or effective for any condition. Availability depends on the pharmacy’s license in the destination state and on whether the substance may be compounded under federal and state law. Prescribing, patient selection and scope of practice are the responsibility of the licensed prescriber. ExaVeyra Sciences is a supplier: it does not provide medical care, does not consult with patients and takes no part in clinical decisions.
Medical devices. Medical devices are sold to licensed practices for the intended use stated in each manufacturer’s labeling, with its instructions for use. The CuraCator is an FDA-listed Class I device (21 CFR 880.6430); listing is neither approval nor clearance, and it does not extend to any product applied with the device. Which product is applied, and how, is the licensed practitioner’s decision. ExaVeyra Sciences is a supplier: it does not provide medical care, does not consult with patients and takes no part in clinical decisions.
Supplier Documentation Reviewed Through an EV Lens
The MISEV 2023 framework gives medspa medical directors a way to evaluate extracellular vesicle documentation. ExaVeyra uses chemist-guided review of supplier records, including particle sizing, identity markers, sterility, endotoxin, and lot-specific testing.
Vesicle Documentation
- NanoSight NTA characterization
- Particle size distribution
- Surface marker review
- Sterility testing
- Mycoplasma and endotoxin records
- COA Per Lot, On Request
Medspa Use Context
- Topical aesthetic application
- Post-procedure workflows
- Medical director review
- Cold-chain guidance
- Device compatibility support
- NPI-verified access
Approved accounts can request supplier documentation and stability information by lot so medical directors can evaluate fit for their practice protocols.
Recommended for Medspas and Aesthetic Clinics
All products require NPI verification and approved wholesale account. COA, lot documentation, and shipping guidance are available for approved practices.
Exosomes
MSC-derived, liquid format, cold-chain shipped, topical aesthetic use, MISEV 2023 framework.
Post-Procedure Serum
Topical post-microneedling application, bioactive formulation, cold-chain shipped.
RF Microneedling Device
Fractional RF, adjustable depth, compatible with topical biologic protocols.
CuraCator Applicator
A sterile, single-use, FDA-listed Class I applicator that spreads a liquid as an even layer on the skin after procedures.
What Medspa Teams Get From Our Supply Chain
NPI-Verified Access Only
Wholesale access is limited to licensed practitioners and practices with an active medical director or supervising physician NPI.
MISEV-Aligned Review
Our chemist-guided evaluation process reviews supplier records through the MISEV 2023 extracellular vesicle documentation framework.
COA Per Lot, On Request
Every biologic lot is supported by documentation covering HPLC, RNA quantification assay, NanoSight NTA characterization, sterility, mycoplasma, endotoxin, and supplier testing records.
Cold-Chain Support
Liquid biomolecular signaling vesicles ship with temperature-monitored cold-chain packaging and expedited fulfillment.
Device Compatibility
RF microneedling devices and microneedling pens can be sourced alongside topical biologic supply.
Medical Director Documentation
Approved accounts can request documentation packages to support internal protocol review and procurement records.
Questions from Medspa and Aesthetic Clinic Teams
What exosome products does ExaVeyra supply for medspas?+
ExaVeyra supplies MSC-derived biomolecular signaling vesicles for topical aesthetic use by licensed practitioners. Available in liquid format, cold-chain shipped. All products are supplied under the MISEV 2023 framework with a COA per lot on request, NanoSight NTA characterization, and cold-chain shipping. For medspa use, products are labeled for topical aesthetic application only.
Are your exosomes FDA-approved?+
No exosome product currently holds FDA approval for therapeutic use in humans. ExaVeyra supplies biomolecular signaling vesicles for topical aesthetic use by licensed practitioners. The manufacturer is named on every product page so its registration can be checked; cGMP documentation is available on request. Practitioners are responsible for compliance with applicable regulations.
What is the MISEV 2023 framework?+
MISEV 2023 is the Minimal Information for Studies of Extracellular Vesicles guidelines published by the International Society for Extracellular Vesicles. ExaVeyra uses this framework to evaluate supplier documentation including particle size distribution, surface marker verification, and sterility testing. Our chemist-guided COA evaluation guide covers all 12 MISEV-aligned parameters.
Do you supply devices compatible with topical exosome protocols?+
Yes. ExaVeyra supplies RF microneedling devices and standard microneedling pens that are commonly used in conjunction with topical biologic protocols. Device compatibility documentation is available on request.
What are your shipping requirements for liquid exosomes?+
Liquid biomolecular signaling vesicles require cold-chain shipping. ExaVeyra uses temperature-monitored packaging with expedited fulfillment. Contact our team for stability data per lot.
Can medspas without a medical director apply for wholesale access?+
ExaVeyra supplies to NPI-verified licensed practitioners. A medical director or supervising physician with an active NPI is required for wholesale account approval. Our team can advise on the documentation required during the application process.